DocetaxelLiver toxicity following an off-label use of docetaxel for metastatic hormone-naive prostate cancer: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1716卷 / 1期

关键词：

D O I：

10.1007/s40278-018-50920-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：122 / 122

相关论文

共 50 条

[21] MethotrexateSteatohepatitis following off-label use: case report
Reactions Weekly, 2019, 1768 (1) : 225 - 225
[22] AzacitidineDiarrhoea following off-label use: case report
Reactions Weekly, 2019, 1736 (1) : 48 - 48
[23] TocilizumabNeutropenia following off-label use: case report
Reactions Weekly, 2021, 1853 (1) : 446 - 446
[24] SunitinibCardiomyopathy following off-label use: case report
Reactions Weekly, 2023, 1971 (1) : 240 - 240
[25] PrednisoloneInefficacy following off-label use: case report
Reactions Weekly, 2022, 1910 (1) : 405 - 405
[26] DaratumumabHypogammaglobulinemia following off-label use: case report
Reactions Weekly, 2019, 1744 (1) : 111 - 111
[27] NivolumabPsoriasis following an off-label use: case report
Reactions Weekly, 2018, 1717 (1) : 214 - 214
[28] GlibenclamideHypoglycaemia following off-label use: case report
Reactions Weekly, 2021, 1857 (1) : 162 - 162
[29] CatequentinibPneumothorax following off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 158 - 158
[30] TolvaptanHypernatraemia following off-label use: case report
Reactions Weekly, 2019, 1753 (1) : 326 - 326

← 1 2 3 4 5 →